Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Navneet S. Majhail(Sarah Cannon), C. Frederick LeMaistre(Sarah Cannon), James Omel(Island Institute), Paul A. Carpenter(Fred Hutch Cancer Center), Stephanie Farnia(National Marrow Donor Program), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Paul J. Orchard(University of Minnesota), Jeanne Palmer(Mayo Clinic), Wael Saber(Medical College of Wisconsin), Paul Veys(Great Ormond Street Hospital), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Stephen W. Crawford, Christopher Bredeson
Cited by 409
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k